

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 7.94760869 |
| 2 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.87558125 |
| 3 | synaptic vesicle maturation (GO:0016188) | 6.79313537 |
| 4 | glutamate secretion (GO:0014047) | 6.23142131 |
| 5 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.17402495 |
| 6 | ensheathment of neurons (GO:0007272) | 6.14402814 |
| 7 | axon ensheathment (GO:0008366) | 6.14402814 |
| 8 | myelination (GO:0042552) | 6.05674004 |
| 9 | myelin maintenance (GO:0043217) | 6.04924352 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 5.84598022 |
| 11 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.84336056 |
| 12 | creatine metabolic process (GO:0006600) | 5.64778316 |
| 13 | cellular potassium ion homeostasis (GO:0030007) | 5.51897199 |
| 14 | negative regulation of protein localization to cell surface (GO:2000009) | 5.34610764 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.32771662 |
| 16 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.23399933 |
| 17 | sodium ion export (GO:0071436) | 5.08413900 |
| 18 | amyloid precursor protein metabolic process (GO:0042982) | 4.83936102 |
| 19 | establishment of mitochondrion localization (GO:0051654) | 4.81014846 |
| 20 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.76849960 |
| 21 | sensory perception of smell (GO:0007608) | 4.74221507 |
| 22 | regulation of synaptic vesicle transport (GO:1902803) | 4.67944700 |
| 23 | response to methylmercury (GO:0051597) | 4.65371257 |
| 24 | cholesterol biosynthetic process (GO:0006695) | 4.57608149 |
| 25 | membrane tubulation (GO:0097320) | 4.56193514 |
| 26 | neurotransmitter secretion (GO:0007269) | 4.55242763 |
| 27 | amino acid import (GO:0043090) | 4.47035334 |
| 28 | neuronal ion channel clustering (GO:0045161) | 4.41717322 |
| 29 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.36513377 |
| 30 | cerebellar granule cell differentiation (GO:0021707) | 4.34502405 |
| 31 | positive regulation of synapse maturation (GO:0090129) | 4.28853569 |
| 32 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.18847494 |
| 33 | locomotory exploration behavior (GO:0035641) | 4.16636314 |
| 34 | potassium ion homeostasis (GO:0055075) | 4.15240076 |
| 35 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.10542670 |
| 36 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.06892371 |
| 37 | sterol biosynthetic process (GO:0016126) | 4.06287586 |
| 38 | negative regulation of neurotransmitter transport (GO:0051589) | 4.02632126 |
| 39 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.02202175 |
| 40 | regulation of collateral sprouting (GO:0048670) | 4.01539426 |
| 41 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.98452908 |
| 42 | regulation of lipoprotein metabolic process (GO:0050746) | 3.97362613 |
| 43 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.97243969 |
| 44 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.82695141 |
| 45 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.80460029 |
| 46 | postsynaptic membrane organization (GO:0001941) | 3.80319385 |
| 47 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.80040350 |
| 48 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.73864332 |
| 49 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.72804832 |
| 50 | neurotransmitter transport (GO:0006836) | 3.72392509 |
| 51 | photoreceptor cell differentiation (GO:0046530) | 3.71637128 |
| 52 | eye photoreceptor cell differentiation (GO:0001754) | 3.71637128 |
| 53 | vocalization behavior (GO:0071625) | 3.69840405 |
| 54 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.66729387 |
| 55 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.64468166 |
| 56 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.64375317 |
| 57 | regulation of ARF protein signal transduction (GO:0032012) | 3.63613784 |
| 58 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.62427784 |
| 59 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.61531691 |
| 60 | response to lipoprotein particle (GO:0055094) | 3.60898185 |
| 61 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.52429505 |
| 62 | isoprenoid biosynthetic process (GO:0008299) | 3.50371784 |
| 63 | cell communication by electrical coupling (GO:0010644) | 3.50059092 |
| 64 | regulation of synapse maturation (GO:0090128) | 3.49579520 |
| 65 | regulation of synaptic plasticity (GO:0048167) | 3.48129523 |
| 66 | regulation of neurotransmitter levels (GO:0001505) | 3.47352556 |
| 67 | exploration behavior (GO:0035640) | 3.45209440 |
| 68 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.44067722 |
| 69 | thioester biosynthetic process (GO:0035384) | 3.41472730 |
| 70 | acyl-CoA biosynthetic process (GO:0071616) | 3.41472730 |
| 71 | neuromuscular process controlling balance (GO:0050885) | 3.39521761 |
| 72 | positive regulation of dendritic spine development (GO:0060999) | 3.39290869 |
| 73 | acidic amino acid transport (GO:0015800) | 3.36211839 |
| 74 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.35494664 |
| 75 | astrocyte development (GO:0014002) | 3.33055449 |
| 76 | neuromuscular synaptic transmission (GO:0007274) | 3.31466757 |
| 77 | oligodendrocyte differentiation (GO:0048709) | 3.31385115 |
| 78 | membrane depolarization during action potential (GO:0086010) | 3.31135692 |
| 79 | regulation of neurotransmitter secretion (GO:0046928) | 3.29421345 |
| 80 | synaptic transmission, glutamatergic (GO:0035249) | 3.28985670 |
| 81 | cellular sodium ion homeostasis (GO:0006883) | 3.28196557 |
| 82 | import into cell (GO:0098657) | 3.28006978 |
| 83 | amyloid precursor protein catabolic process (GO:0042987) | 3.27020808 |
| 84 | L-amino acid import (GO:0043092) | 3.25854947 |
| 85 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.25032565 |
| 86 | positive regulation of membrane potential (GO:0045838) | 3.22714512 |
| 87 | regulation of synapse structural plasticity (GO:0051823) | 3.22535346 |
| 88 | GPI anchor biosynthetic process (GO:0006506) | 3.21391539 |
| 89 | protein palmitoylation (GO:0018345) | 3.19098014 |
| 90 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.19064718 |
| 91 | substantia nigra development (GO:0021762) | 3.17646450 |
| 92 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.16775416 |
| 93 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.16393177 |
| 94 | regulation of dendritic spine development (GO:0060998) | 3.14995374 |
| 95 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.13637266 |
| 96 | magnesium ion transport (GO:0015693) | 3.12578317 |
| 97 | regulation of neurotransmitter transport (GO:0051588) | 3.09420762 |
| 98 | regulation of relaxation of muscle (GO:1901077) | 3.07625352 |
| 99 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.07213893 |
| 100 | long-term synaptic potentiation (GO:0060291) | 3.06073953 |
| 101 | negative regulation of inclusion body assembly (GO:0090084) | 3.05549603 |
| 102 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.05441767 |
| 103 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.04880787 |
| 104 | glycerophospholipid catabolic process (GO:0046475) | 3.03331883 |
| 105 | long-term memory (GO:0007616) | 3.02445517 |
| 106 | neuron cell-cell adhesion (GO:0007158) | 3.02310753 |
| 107 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.02036129 |
| 108 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.01119191 |
| 109 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.01114026 |
| 110 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.00977787 |
| 111 | neuron-neuron synaptic transmission (GO:0007270) | 3.00449737 |
| 112 | L-glutamate transport (GO:0015813) | 3.00173191 |
| 113 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.99692844 |
| 114 | response to redox state (GO:0051775) | 2.99453850 |
| 115 | GPI anchor metabolic process (GO:0006505) | 2.99143442 |
| 116 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.98659709 |
| 117 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.98087639 |
| 118 | positive regulation of Rap GTPase activity (GO:0032854) | 2.97411012 |
| 119 | membrane raft organization (GO:0031579) | 2.96901287 |
| 120 | striated muscle contraction (GO:0006941) | 2.96426954 |
| 121 | activation of protein kinase A activity (GO:0034199) | 2.96421523 |
| 122 | glutamate receptor signaling pathway (GO:0007215) | 2.95790155 |
| 123 | regulation of postsynaptic membrane potential (GO:0060078) | 2.95724266 |
| 124 | synaptic vesicle endocytosis (GO:0048488) | 2.93052975 |
| 125 | regulation of actin filament-based movement (GO:1903115) | 2.92959435 |
| 126 | regulation of vesicle fusion (GO:0031338) | 2.91307556 |
| 127 | Golgi to endosome transport (GO:0006895) | 2.91039071 |
| 128 | proline transport (GO:0015824) | 2.90166764 |
| 129 | protein localization to synapse (GO:0035418) | 2.89980759 |
| 130 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.89247440 |
| 131 | skeletal muscle contraction (GO:0003009) | 2.88987263 |
| 132 | asymmetric protein localization (GO:0008105) | 2.87782632 |
| 133 | membrane depolarization (GO:0051899) | 2.86363074 |
| 134 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.86149146 |
| 135 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.86149146 |
| 136 | nerve growth factor signaling pathway (GO:0038180) | 2.84150564 |
| 137 | sarcomere organization (GO:0045214) | 2.82795654 |
| 138 | peripheral nervous system axon ensheathment (GO:0032292) | 2.82071633 |
| 139 | myelination in peripheral nervous system (GO:0022011) | 2.82071633 |
| 140 | cellular response to epinephrine stimulus (GO:0071872) | 2.81935645 |
| 141 | response to epinephrine (GO:0071871) | 2.79797653 |
| 142 | positive regulation of glial cell differentiation (GO:0045687) | 2.78462519 |
| 143 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.77152480 |
| 144 | axon development (GO:0061564) | 2.76547911 |
| 145 | very long-chain fatty acid metabolic process (GO:0000038) | 2.73602080 |
| 146 | adult walking behavior (GO:0007628) | 2.68688733 |
| 147 | response to inactivity (GO:0014854) | 2.68515511 |
| 148 | sensory perception of chemical stimulus (GO:0007606) | 2.68286617 |
| 149 | regulation of cell communication by electrical coupling (GO:0010649) | 2.67744035 |
| 150 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.67496368 |
| 151 | neurotransmitter uptake (GO:0001504) | 2.66381237 |
| 152 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.65749978 |
| 153 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.63110789 |
| 154 | potassium ion import (GO:0010107) | 2.62463392 |
| 155 | negative regulation of chemokine production (GO:0032682) | 2.58369052 |
| 156 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.58061107 |
| 157 | apical protein localization (GO:0045176) | 2.57538401 |
| 158 | negative regulation of axonogenesis (GO:0050771) | 2.56921000 |
| 159 | tissue regeneration (GO:0042246) | 2.56703375 |
| 160 | positive regulation of gliogenesis (GO:0014015) | 2.56531467 |
| 161 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.55510695 |
| 162 | mitochondrion transport along microtubule (GO:0047497) | 2.55510695 |
| 163 | cellular response to catecholamine stimulus (GO:0071870) | 2.55163467 |
| 164 | cellular response to monoamine stimulus (GO:0071868) | 2.55163467 |
| 165 | protein localization to endosome (GO:0036010) | 2.54775851 |
| 166 | response to catecholamine (GO:0071869) | 2.49383101 |
| 167 | response to monoamine (GO:0071867) | 2.49383101 |
| 168 | regulation of somitogenesis (GO:0014807) | 2.47601843 |
| 169 | presynaptic membrane organization (GO:0097090) | 2.47227728 |
| 170 | cortical actin cytoskeleton organization (GO:0030866) | 2.46621351 |
| 171 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.46009409 |
| 172 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.46009409 |
| 173 | organ growth (GO:0035265) | 2.46007668 |
| 174 | myofibril assembly (GO:0030239) | 2.45630054 |
| 175 | glycosylceramide metabolic process (GO:0006677) | 2.44450685 |
| 176 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.44269624 |
| 177 | actin-myosin filament sliding (GO:0033275) | 2.44096811 |
| 178 | muscle filament sliding (GO:0030049) | 2.44096811 |
| 179 | neuronal action potential propagation (GO:0019227) | 2.43782947 |
| 180 | axon ensheathment in central nervous system (GO:0032291) | 11.3923593 |
| 181 | central nervous system myelination (GO:0022010) | 11.3923593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.06204598 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.97196031 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.90891630 |
| 4 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.90248625 |
| 5 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.78419683 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.59961118 |
| 7 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.47856294 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.46936272 |
| 9 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.46641628 |
| 10 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.28395215 |
| 11 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.22169000 |
| 12 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.95747591 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.89566473 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.86709546 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.83029036 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.79526679 |
| 17 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.76062765 |
| 18 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.73763532 |
| 19 | KDM2B_26808549_Chip-Seq_K562_Human | 1.70676384 |
| 20 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.68909808 |
| 21 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68788374 |
| 22 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.67264261 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.65077978 |
| 24 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.64078284 |
| 25 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.62280479 |
| 26 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.62055077 |
| 27 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.60925738 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.59766889 |
| 29 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.59180562 |
| 30 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.56768808 |
| 31 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.55831142 |
| 32 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.52946855 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.52065205 |
| 34 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50928964 |
| 35 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.49898446 |
| 36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45636944 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45573781 |
| 38 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.45135951 |
| 39 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.43289475 |
| 40 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.43289475 |
| 41 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42848657 |
| 42 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.41643410 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.39424898 |
| 44 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.36722759 |
| 45 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.36110433 |
| 46 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.35194840 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33712171 |
| 48 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.33474060 |
| 49 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.30962445 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.30949389 |
| 51 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.30757215 |
| 52 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.30462749 |
| 53 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.29400286 |
| 54 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.28965955 |
| 55 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27522163 |
| 56 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.24694747 |
| 57 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24332181 |
| 58 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.21745418 |
| 59 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.21686412 |
| 60 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.21469583 |
| 61 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.21335336 |
| 62 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.20785548 |
| 63 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.20606402 |
| 64 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.20226293 |
| 65 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.20137258 |
| 66 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.15843505 |
| 67 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15403326 |
| 68 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.14052454 |
| 69 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.14052454 |
| 70 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.13966476 |
| 71 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13534508 |
| 72 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.13052916 |
| 73 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.11642905 |
| 74 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.11153309 |
| 75 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.10874448 |
| 76 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09924296 |
| 77 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08959679 |
| 78 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.08094973 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07731472 |
| 80 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.05062931 |
| 81 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.04562616 |
| 82 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.03814442 |
| 83 | AR_19668381_ChIP-Seq_PC3_Human | 1.03090058 |
| 84 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02712596 |
| 85 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.02560374 |
| 86 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.00347679 |
| 87 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.99832693 |
| 88 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99769638 |
| 89 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.99492968 |
| 90 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98269331 |
| 91 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.98263842 |
| 92 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.95886001 |
| 93 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.95200264 |
| 94 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.94886478 |
| 95 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.93381338 |
| 96 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.93318409 |
| 97 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92887335 |
| 98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.91923302 |
| 99 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.91661321 |
| 100 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91494682 |
| 101 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.91147235 |
| 102 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.90975596 |
| 103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90631831 |
| 104 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.90114683 |
| 105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89081432 |
| 106 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.88244842 |
| 107 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88127593 |
| 108 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.87604684 |
| 109 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87553929 |
| 110 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.87351799 |
| 111 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.87085817 |
| 112 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.86797942 |
| 113 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.84157285 |
| 114 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83911629 |
| 115 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.83885144 |
| 116 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.83885144 |
| 117 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.83621444 |
| 118 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.83568672 |
| 119 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.83298880 |
| 120 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82605013 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82587823 |
| 122 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.81918036 |
| 123 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.81810240 |
| 124 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.81411650 |
| 125 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.81187334 |
| 126 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.81137690 |
| 127 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.80759990 |
| 128 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80657866 |
| 129 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80604108 |
| 130 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.80507404 |
| 131 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.80315690 |
| 132 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79748482 |
| 133 | STAT3_23295773_ChIP-Seq_U87_Human | 0.79619466 |
| 134 | P68_20966046_ChIP-Seq_HELA_Human | 0.79409495 |
| 135 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.78026312 |
| 136 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.77533888 |
| 137 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.77105686 |
| 138 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76751577 |
| 139 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76751577 |
| 140 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.76292656 |
| 141 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.76029828 |
| 142 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.75091217 |
| 143 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.74760714 |
| 144 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.74382970 |
| 145 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.74348429 |
| 146 | SPI1_23127762_ChIP-Seq_K562_Human | 0.74192161 |
| 147 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.74099329 |
| 148 | SA1_27219007_Chip-Seq_Bcells_Human | 0.74070817 |
| 149 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.73942899 |
| 150 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.73520167 |
| 151 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.73072641 |
| 152 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.73030966 |
| 153 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.72665900 |
| 154 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.72271705 |
| 155 | TP53_16413492_ChIP-PET_HCT116_Human | 0.72047232 |
| 156 | TBL1_22424771_ChIP-Seq_293T_Human | 0.71858944 |
| 157 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.70578012 |
| 158 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.69671186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.79700251 |
| 2 | MP0000920_abnormal_myelination | 5.42783661 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.88001770 |
| 4 | MP0002063_abnormal_learning/memory/cond | 2.80282164 |
| 5 | MP0001984_abnormal_olfaction | 2.76614290 |
| 6 | MP0004036_abnormal_muscle_relaxation | 2.58376205 |
| 7 | MP0000751_myopathy | 2.55404118 |
| 8 | MP0000749_muscle_degeneration | 2.51295782 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 2.42691757 |
| 10 | MP0001529_abnormal_vocalization | 2.42460983 |
| 11 | MP0003329_amyloid_beta_deposits | 2.32270951 |
| 12 | MP0000747_muscle_weakness | 2.30566541 |
| 13 | MP0004145_abnormal_muscle_electrophysio | 2.30322307 |
| 14 | MP0004270_analgesia | 2.29654938 |
| 15 | MP0003879_abnormal_hair_cell | 2.26358977 |
| 16 | MP0005409_darkened_coat_color | 2.26222557 |
| 17 | MP0003690_abnormal_glial_cell | 2.25754510 |
| 18 | MP0002272_abnormal_nervous_system | 2.22144534 |
| 19 | MP0002572_abnormal_emotion/affect_behav | 2.19210814 |
| 20 | MP0003880_abnormal_central_pattern | 2.16558682 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 2.11444129 |
| 22 | MP0001501_abnormal_sleep_pattern | 2.08429542 |
| 23 | MP0001968_abnormal_touch/_nociception | 2.07674904 |
| 24 | MP0004742_abnormal_vestibular_system | 2.04361747 |
| 25 | MP0001905_abnormal_dopamine_level | 2.03762988 |
| 26 | MP0001485_abnormal_pinna_reflex | 2.02435757 |
| 27 | MP0003634_abnormal_glial_cell | 2.00835660 |
| 28 | MP0004142_abnormal_muscle_tone | 2.00778828 |
| 29 | MP0001486_abnormal_startle_reflex | 1.93309587 |
| 30 | MP0004381_abnormal_hair_follicle | 1.80787815 |
| 31 | MP0005410_abnormal_fertilization | 1.79709790 |
| 32 | MP0005451_abnormal_body_composition | 1.77316887 |
| 33 | MP0003806_abnormal_nucleotide_metabolis | 1.73205137 |
| 34 | MP0004084_abnormal_cardiac_muscle | 1.71488843 |
| 35 | MP0005330_cardiomyopathy | 1.70586705 |
| 36 | MP0004215_abnormal_myocardial_fiber | 1.62057356 |
| 37 | MP0002229_neurodegeneration | 1.61496186 |
| 38 | MP0004147_increased_porphyrin_level | 1.61202380 |
| 39 | MP0002735_abnormal_chemical_nociception | 1.60810077 |
| 40 | MP0008569_lethality_at_weaning | 1.54335853 |
| 41 | MP0002733_abnormal_thermal_nociception | 1.52969817 |
| 42 | MP0003137_abnormal_impulse_conducting | 1.52891728 |
| 43 | MP0002106_abnormal_muscle_physiology | 1.49370854 |
| 44 | MP0005423_abnormal_somatic_nervous | 1.48795684 |
| 45 | MP0004885_abnormal_endolymph | 1.47572818 |
| 46 | MP0002064_seizures | 1.45514093 |
| 47 | MP0004087_abnormal_muscle_fiber | 1.45350780 |
| 48 | MP0004811_abnormal_neuron_physiology | 1.45064338 |
| 49 | MP0001502_abnormal_circadian_rhythm | 1.40388725 |
| 50 | MP0003136_yellow_coat_color | 1.40358814 |
| 51 | MP0004043_abnormal_pH_regulation | 1.39318008 |
| 52 | MP0003633_abnormal_nervous_system | 1.37210762 |
| 53 | MP0003631_nervous_system_phenotype | 1.36944982 |
| 54 | MP0001440_abnormal_grooming_behavior | 1.35516288 |
| 55 | MP0003632_abnormal_nervous_system | 1.33170097 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.32437301 |
| 57 | MP0005171_absent_coat_pigmentation | 1.31182497 |
| 58 | MP0005620_abnormal_muscle_contractility | 1.29489019 |
| 59 | MP0005646_abnormal_pituitary_gland | 1.26474269 |
| 60 | MP0005369_muscle_phenotype | 1.24171993 |
| 61 | MP0002972_abnormal_cardiac_muscle | 1.23718800 |
| 62 | MP0004484_altered_response_of | 1.23027772 |
| 63 | MP0002736_abnormal_nociception_after | 1.22093578 |
| 64 | MP0006082_CNS_inflammation | 1.21223994 |
| 65 | MP0000759_abnormal_skeletal_muscle | 1.21117477 |
| 66 | MP0003787_abnormal_imprinting | 1.17116129 |
| 67 | MP0000778_abnormal_nervous_system | 1.14742941 |
| 68 | MP0008260_abnormal_autophagy | 1.14718540 |
| 69 | MP0002557_abnormal_social/conspecific_i | 1.14559788 |
| 70 | MP0002734_abnormal_mechanical_nocicepti | 1.11281681 |
| 71 | MP0006036_abnormal_mitochondrial_physio | 1.10097543 |
| 72 | MP0010678_abnormal_skin_adnexa | 1.08766325 |
| 73 | MP0004085_abnormal_heartbeat | 1.08716275 |
| 74 | MP0000604_amyloidosis | 1.08577535 |
| 75 | MP0004134_abnormal_chest_morphology | 1.08137132 |
| 76 | MP0003075_altered_response_to | 1.06655764 |
| 77 | MP0004510_myositis | 1.06447994 |
| 78 | MP0001986_abnormal_taste_sensitivity | 1.05897193 |
| 79 | MP0001177_atelectasis | 1.05529181 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 1.05321003 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 1.05229273 |
| 82 | MP0002332_abnormal_exercise_endurance | 1.05014495 |
| 83 | MP0001346_abnormal_lacrimal_gland | 1.02502900 |
| 84 | MP0002822_catalepsy | 1.02045191 |
| 85 | MP0004185_abnormal_adipocyte_glucose | 1.00939547 |
| 86 | MP0001970_abnormal_pain_threshold | 1.00182677 |
| 87 | MP0000383_abnormal_hair_follicle | 0.99013912 |
| 88 | MP0000003_abnormal_adipose_tissue | 0.98415505 |
| 89 | MP0001851_eye_inflammation | 0.98090721 |
| 90 | MP0005623_abnormal_meninges_morphology | 0.97497389 |
| 91 | MP0002882_abnormal_neuron_morphology | 0.97445744 |
| 92 | MP0003646_muscle_fatigue | 0.95577943 |
| 93 | MP0003045_fibrosis | 0.94573604 |
| 94 | MP0003635_abnormal_synaptic_transmissio | 0.93529631 |
| 95 | MP0009745_abnormal_behavioral_response | 0.92962006 |
| 96 | MP0003123_paternal_imprinting | 0.92319153 |
| 97 | MP0002067_abnormal_sensory_capabilities | 0.92058725 |
| 98 | MP0001790_abnormal_immune_system | 0.92003061 |
| 99 | MP0005387_immune_system_phenotype | 0.92003061 |
| 100 | MP0008775_abnormal_heart_ventricle | 0.91622333 |
| 101 | MP0004130_abnormal_muscle_cell | 0.91366768 |
| 102 | MP0002066_abnormal_motor_capabilities/c | 0.90012129 |
| 103 | MP0004924_abnormal_behavior | 0.89435397 |
| 104 | MP0005386_behavior/neurological_phenoty | 0.89435397 |
| 105 | MP0006276_abnormal_autonomic_nervous | 0.88657139 |
| 106 | MP0002752_abnormal_somatic_nervous | 0.87818378 |
| 107 | MP0000372_irregular_coat_pigmentation | 0.87156440 |
| 108 | MP0005551_abnormal_eye_electrophysiolog | 0.86831750 |
| 109 | MP0000955_abnormal_spinal_cord | 0.85511885 |
| 110 | MP0000462_abnormal_digestive_system | 0.84636589 |
| 111 | MP0010630_abnormal_cardiac_muscle | 0.84524433 |
| 112 | MP0001348_abnormal_lacrimal_gland | 0.84354469 |
| 113 | MP0002152_abnormal_brain_morphology | 0.83378565 |
| 114 | MP0002933_joint_inflammation | 0.82810301 |
| 115 | MP0000685_abnormal_immune_system | 0.82440144 |
| 116 | MP0005645_abnormal_hypothalamus_physiol | 0.81591944 |
| 117 | MP0009046_muscle_twitch | 0.80690639 |
| 118 | MP0002269_muscular_atrophy | 0.80207568 |
| 119 | MP0005375_adipose_tissue_phenotype | 0.80196554 |
| 120 | MP0008874_decreased_physiological_sensi | 0.79434369 |
| 121 | MP0000465_gastrointestinal_hemorrhage | 0.79299473 |
| 122 | MP0002184_abnormal_innervation | 0.78604766 |
| 123 | MP0005535_abnormal_body_temperature | 0.78604530 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.78572085 |
| 125 | MP0001661_extended_life_span | 0.76592225 |
| 126 | MP0000750_abnormal_muscle_regeneration | 0.73797444 |
| 127 | MP0001299_abnormal_eye_distance/ | 0.72949605 |
| 128 | MP0001963_abnormal_hearing_physiology | 0.72559694 |
| 129 | MP0005166_decreased_susceptibility_to | 0.72271196 |
| 130 | MP0005165_increased_susceptibility_to | 0.68954255 |
| 131 | MP0003122_maternal_imprinting | 0.58479569 |
| 132 | MP0002638_abnormal_pupillary_reflex | 0.57724149 |
| 133 | MP0000733_abnormal_muscle_development | 0.54090654 |
| 134 | MP0002069_abnormal_eating/drinking_beha | 0.53366581 |
| 135 | MP0001943_abnormal_respiration | 0.51645818 |
| 136 | MP0004233_abnormal_muscle_weight | 0.49743632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.37155038 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.37155038 |
| 3 | Focal motor seizures (HP:0011153) | 5.13006080 |
| 4 | Neurofibrillary tangles (HP:0002185) | 4.79716003 |
| 5 | Termporal pattern (HP:0011008) | 4.66626853 |
| 6 | Insidious onset (HP:0003587) | 4.66626853 |
| 7 | Onion bulb formation (HP:0003383) | 4.65415075 |
| 8 | Abnormality of the corticospinal tract (HP:0002492) | 4.58974527 |
| 9 | Peripheral hypomyelination (HP:0007182) | 4.43323938 |
| 10 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.41553606 |
| 11 | Focal seizures (HP:0007359) | 4.32900086 |
| 12 | Muscle fiber splitting (HP:0003555) | 4.16876122 |
| 13 | Abnormality of binocular vision (HP:0011514) | 4.11462250 |
| 14 | Diplopia (HP:0000651) | 4.11462250 |
| 15 | Febrile seizures (HP:0002373) | 4.06597430 |
| 16 | Retinal dysplasia (HP:0007973) | 4.02877718 |
| 17 | Parakeratosis (HP:0001036) | 4.00975495 |
| 18 | Calf muscle hypertrophy (HP:0008981) | 3.87838971 |
| 19 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.80398405 |
| 20 | Epileptic encephalopathy (HP:0200134) | 3.71804604 |
| 21 | Type 1 muscle fiber predominance (HP:0003803) | 3.70695557 |
| 22 | Atonic seizures (HP:0010819) | 3.64614976 |
| 23 | Hyporeflexia of lower limbs (HP:0002600) | 3.64303063 |
| 24 | Obstructive sleep apnea (HP:0002870) | 3.45014204 |
| 25 | Cerebral inclusion bodies (HP:0100314) | 3.43937894 |
| 26 | Foot dorsiflexor weakness (HP:0009027) | 3.41364115 |
| 27 | Distal arthrogryposis (HP:0005684) | 3.39107815 |
| 28 | Spastic gait (HP:0002064) | 3.37047885 |
| 29 | Supranuclear gaze palsy (HP:0000605) | 3.32089031 |
| 30 | Sudden death (HP:0001699) | 3.30218926 |
| 31 | Bundle branch block (HP:0011710) | 3.29296291 |
| 32 | Abnormality of the foot musculature (HP:0001436) | 3.26399362 |
| 33 | Ankle clonus (HP:0011448) | 3.24574388 |
| 34 | Exercise-induced myalgia (HP:0003738) | 3.23210388 |
| 35 | Sensory axonal neuropathy (HP:0003390) | 3.18742172 |
| 36 | Generalized tonic-clonic seizures (HP:0002069) | 3.14668408 |
| 37 | Visual hallucinations (HP:0002367) | 3.13287433 |
| 38 | Myopathic facies (HP:0002058) | 3.10209089 |
| 39 | Postural instability (HP:0002172) | 3.09535430 |
| 40 | Leukodystrophy (HP:0002415) | 3.06523800 |
| 41 | Abnormality of glycolysis (HP:0004366) | 3.04600275 |
| 42 | Increased serum pyruvate (HP:0003542) | 3.04600275 |
| 43 | Difficulty running (HP:0009046) | 3.02963783 |
| 44 | Fetal akinesia sequence (HP:0001989) | 2.95574829 |
| 45 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.91572700 |
| 46 | Papilledema (HP:0001085) | 2.91489521 |
| 47 | Stridor (HP:0010307) | 2.88189912 |
| 48 | Cerebral hemorrhage (HP:0001342) | 2.86252916 |
| 49 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.85232880 |
| 50 | Slow saccadic eye movements (HP:0000514) | 2.85228031 |
| 51 | Akinesia (HP:0002304) | 2.80052681 |
| 52 | Gowers sign (HP:0003391) | 2.79555889 |
| 53 | Cerebral hypomyelination (HP:0006808) | 2.79031823 |
| 54 | Pheochromocytoma (HP:0002666) | 2.78356977 |
| 55 | Hemiplegia (HP:0002301) | 2.73752062 |
| 56 | Abnormal auditory evoked potentials (HP:0006958) | 2.73673416 |
| 57 | Dysmetria (HP:0001310) | 2.72413258 |
| 58 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.69910844 |
| 59 | Abnormal eating behavior (HP:0100738) | 2.69665881 |
| 60 | Absence seizures (HP:0002121) | 2.66948346 |
| 61 | Tetraplegia (HP:0002445) | 2.64132508 |
| 62 | Clonus (HP:0002169) | 2.58659743 |
| 63 | Progressive cerebellar ataxia (HP:0002073) | 2.57629038 |
| 64 | Rigidity (HP:0002063) | 2.57367197 |
| 65 | Abnormality of the calf musculature (HP:0001430) | 2.57073812 |
| 66 | Neuroendocrine neoplasm (HP:0100634) | 2.55967336 |
| 67 | Spastic tetraparesis (HP:0001285) | 2.54407395 |
| 68 | Prolonged QT interval (HP:0001657) | 2.53841546 |
| 69 | Lower limb amyotrophy (HP:0007210) | 2.49469491 |
| 70 | Dialeptic seizures (HP:0011146) | 2.47366712 |
| 71 | Hammertoe (HP:0001765) | 2.45534368 |
| 72 | EMG: neuropathic changes (HP:0003445) | 2.44890810 |
| 73 | Axonal loss (HP:0003447) | 2.42911289 |
| 74 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.42492191 |
| 75 | Rapidly progressive (HP:0003678) | 2.41312610 |
| 76 | Truncal ataxia (HP:0002078) | 2.41114480 |
| 77 | Atrial fibrillation (HP:0005110) | 2.40204428 |
| 78 | Heart block (HP:0012722) | 2.40100832 |
| 79 | Decreased motor nerve conduction velocity (HP:0003431) | 2.39760139 |
| 80 | Limb dystonia (HP:0002451) | 2.39700626 |
| 81 | EMG: myopathic abnormalities (HP:0003458) | 2.37487487 |
| 82 | Poor eye contact (HP:0000817) | 2.35637041 |
| 83 | Acute necrotizing encephalopathy (HP:0006965) | 2.34050936 |
| 84 | Torticollis (HP:0000473) | 2.34035958 |
| 85 | Annular pancreas (HP:0001734) | 2.32085308 |
| 86 | Dysdiadochokinesis (HP:0002075) | 2.30652845 |
| 87 | Steppage gait (HP:0003376) | 2.30406380 |
| 88 | Depression (HP:0000716) | 2.30349113 |
| 89 | Mutism (HP:0002300) | 2.30087281 |
| 90 | Neuronal loss in central nervous system (HP:0002529) | 2.29716246 |
| 91 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.29395475 |
| 92 | Frequent falls (HP:0002359) | 2.27797290 |
| 93 | Increased circulating renin level (HP:0000848) | 2.27647455 |
| 94 | Urinary urgency (HP:0000012) | 2.27190750 |
| 95 | Intention tremor (HP:0002080) | 2.25963042 |
| 96 | Ulnar deviation of the wrist (HP:0003049) | 2.25314975 |
| 97 | Methylmalonic acidemia (HP:0002912) | 2.24944098 |
| 98 | Ventricular fibrillation (HP:0001663) | 2.24110754 |
| 99 | Ulnar claw (HP:0001178) | 2.22976968 |
| 100 | Scanning speech (HP:0002168) | 2.22615010 |
| 101 | Lower limb muscle weakness (HP:0007340) | 2.22252113 |
| 102 | Choreoathetosis (HP:0001266) | 2.21907561 |
| 103 | Syncope (HP:0001279) | 2.21811255 |
| 104 | Delusions (HP:0000746) | 2.20841056 |
| 105 | Abnormal atrioventricular conduction (HP:0005150) | 2.20687005 |
| 106 | Type II lissencephaly (HP:0007260) | 2.19067551 |
| 107 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.18451277 |
| 108 | Exercise-induced muscle cramps (HP:0003710) | 2.16613518 |
| 109 | Primary atrial arrhythmia (HP:0001692) | 2.16128346 |
| 110 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.15697909 |
| 111 | Sleep apnea (HP:0010535) | 2.15127982 |
| 112 | Autoamputation (HP:0001218) | 2.13554793 |
| 113 | Hepatocellular necrosis (HP:0001404) | 2.12943746 |
| 114 | Muscle fiber inclusion bodies (HP:0100299) | 2.12155840 |
| 115 | Bradykinesia (HP:0002067) | 2.11569017 |
| 116 | Anxiety (HP:0000739) | 2.10928882 |
| 117 | Ventricular tachycardia (HP:0004756) | 2.09555439 |
| 118 | Anteriorly placed anus (HP:0001545) | 2.09213513 |
| 119 | Myoglobinuria (HP:0002913) | 2.07062785 |
| 120 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.07036323 |
| 121 | Nemaline bodies (HP:0003798) | 2.06947492 |
| 122 | Supraventricular tachycardia (HP:0004755) | 2.05687910 |
| 123 | Abnormality of the periventricular white matter (HP:0002518) | 2.04268459 |
| 124 | Rhabdomyolysis (HP:0003201) | 2.04101525 |
| 125 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.03374937 |
| 126 | Myokymia (HP:0002411) | 2.02681235 |
| 127 | Hypoplasia of the iris (HP:0007676) | 2.01714095 |
| 128 | Acute encephalopathy (HP:0006846) | 2.00073311 |
| 129 | Status epilepticus (HP:0002133) | 1.99658316 |
| 130 | Increased variability in muscle fiber diameter (HP:0003557) | 1.99310891 |
| 131 | T lymphocytopenia (HP:0005403) | 1.98555084 |
| 132 | Muscle stiffness (HP:0003552) | 1.97961522 |
| 133 | Supraventricular arrhythmia (HP:0005115) | 1.97783274 |
| 134 | Dilated cardiomyopathy (HP:0001644) | 1.97706441 |
| 135 | Premature skin wrinkling (HP:0100678) | 1.97659132 |
| 136 | Gastrointestinal stroma tumor (HP:0100723) | 1.96517020 |
| 137 | Mitochondrial inheritance (HP:0001427) | 1.95672259 |
| 138 | Clumsiness (HP:0002312) | 1.95018230 |
| 139 | Impaired social interactions (HP:0000735) | 1.94446938 |
| 140 | Abnormal social behavior (HP:0012433) | 1.94446938 |
| 141 | Action tremor (HP:0002345) | 1.94302750 |
| 142 | Progressive macrocephaly (HP:0004481) | 1.93588098 |
| 143 | Lipoatrophy (HP:0100578) | 1.93165072 |
| 144 | Spastic paraparesis (HP:0002313) | 1.92892170 |
| 145 | Infantile muscular hypotonia (HP:0008947) | 1.90990806 |
| 146 | Duplicated collecting system (HP:0000081) | 1.88323226 |
| 147 | Alacrima (HP:0000522) | 1.83893020 |
| 148 | Large for gestational age (HP:0001520) | 1.83682640 |
| 149 | Neck muscle weakness (HP:0000467) | 1.83488730 |
| 150 | Partial agenesis of the corpus callosum (HP:0001338) | 1.82264815 |
| 151 | Absent septum pellucidum (HP:0001331) | 1.82120006 |
| 152 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.80318964 |
| 153 | Subaortic stenosis (HP:0001682) | 1.80318964 |
| 154 | Abnormality of T cell number (HP:0011839) | 1.79942855 |
| 155 | Hypoplastic pelvis (HP:0008839) | 1.79313753 |
| 156 | Distal sensory impairment (HP:0002936) | 1.79063536 |
| 157 | Myotonia (HP:0002486) | 1.78297847 |
| 158 | Round ear (HP:0100830) | 1.77224328 |
| 159 | CNS hypomyelination (HP:0003429) | 1.76976998 |
| 160 | Hepatic necrosis (HP:0002605) | 1.76793463 |
| 161 | Loss of speech (HP:0002371) | 1.76313265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.10918154 |
| 2 | EPHB1 | 4.49364600 |
| 3 | EPHA4 | 3.94711562 |
| 4 | OXSR1 | 3.49865551 |
| 5 | NTRK3 | 3.44922606 |
| 6 | MAPKAPK5 | 3.37150779 |
| 7 | MARK1 | 3.15009122 |
| 8 | DAPK2 | 3.10880832 |
| 9 | PHKG1 | 2.82711031 |
| 10 | PHKG2 | 2.82711031 |
| 11 | PKN1 | 2.76432116 |
| 12 | WNK4 | 2.46408467 |
| 13 | NTRK2 | 2.27669272 |
| 14 | WNK1 | 2.22002509 |
| 15 | PRKD3 | 2.15328716 |
| 16 | CLK1 | 2.09991055 |
| 17 | CAMKK1 | 1.95108464 |
| 18 | RIPK4 | 1.86594720 |
| 19 | MAP3K9 | 1.80023821 |
| 20 | PRPF4B | 1.76514588 |
| 21 | MUSK | 1.73791867 |
| 22 | CAMK2D | 1.71382103 |
| 23 | MAP4K1 | 1.69301324 |
| 24 | UHMK1 | 1.68589254 |
| 25 | MINK1 | 1.65723063 |
| 26 | CDK19 | 1.61566783 |
| 27 | OBSCN | 1.58869274 |
| 28 | CSNK1A1L | 1.56493410 |
| 29 | RIPK1 | 1.55328284 |
| 30 | CAMK2B | 1.52729286 |
| 31 | TTN | 1.52185297 |
| 32 | PAK3 | 1.51441169 |
| 33 | ROCK2 | 1.51165028 |
| 34 | CSNK1G3 | 1.50590085 |
| 35 | MARK2 | 1.43725049 |
| 36 | KSR2 | 1.43597049 |
| 37 | PNCK | 1.43126417 |
| 38 | PRKD1 | 1.38521621 |
| 39 | FGFR2 | 1.28650697 |
| 40 | CSNK1G1 | 1.25096100 |
| 41 | BCR | 1.19073946 |
| 42 | PRKCQ | 1.18304162 |
| 43 | GRK5 | 1.17755208 |
| 44 | TNK2 | 1.17544647 |
| 45 | TESK2 | 1.16448287 |
| 46 | LIMK1 | 1.16225649 |
| 47 | MAPK13 | 1.16132573 |
| 48 | PBK | 1.15543423 |
| 49 | MET | 1.15487474 |
| 50 | ITK | 1.12387760 |
| 51 | SGK494 | 1.11365695 |
| 52 | SGK223 | 1.11365695 |
| 53 | MST4 | 1.10667208 |
| 54 | PLK2 | 1.09196484 |
| 55 | SGK2 | 1.07543490 |
| 56 | SGK3 | 1.03680092 |
| 57 | TRPM7 | 1.03329064 |
| 58 | FGR | 1.02759784 |
| 59 | CAMK2G | 1.02687238 |
| 60 | CSNK1G2 | 0.96106262 |
| 61 | DMPK | 0.96059488 |
| 62 | MAPK15 | 0.95981628 |
| 63 | CAMK1G | 0.93197711 |
| 64 | TNIK | 0.93022081 |
| 65 | LATS2 | 0.92451802 |
| 66 | MAP3K13 | 0.92195842 |
| 67 | MAP3K7 | 0.92108402 |
| 68 | MAPK10 | 0.90450782 |
| 69 | MAPK12 | 0.89702971 |
| 70 | ALK | 0.89391520 |
| 71 | PIK3CA | 0.89324291 |
| 72 | CSF1R | 0.89282314 |
| 73 | SGK1 | 0.86990428 |
| 74 | NTRK1 | 0.84454174 |
| 75 | DYRK1A | 0.84182157 |
| 76 | STK38 | 0.80670977 |
| 77 | DAPK1 | 0.80328009 |
| 78 | CAMK2A | 0.78542847 |
| 79 | RPS6KA5 | 0.77857286 |
| 80 | CDK15 | 0.77448683 |
| 81 | CAMK4 | 0.77071793 |
| 82 | MAP3K11 | 0.76429995 |
| 83 | GRK7 | 0.74905065 |
| 84 | PRKCG | 0.73399381 |
| 85 | CDK18 | 0.72554407 |
| 86 | HIPK2 | 0.72489600 |
| 87 | CDK11A | 0.70970345 |
| 88 | MAP2K4 | 0.70381597 |
| 89 | ILK | 0.68656158 |
| 90 | PDPK1 | 0.67849069 |
| 91 | BTK | 0.66003349 |
| 92 | RPS6KA3 | 0.65014880 |
| 93 | PRKCH | 0.64889963 |
| 94 | BMPR2 | 0.64872268 |
| 95 | LCK | 0.62374344 |
| 96 | DYRK2 | 0.62256533 |
| 97 | ICK | 0.58554038 |
| 98 | CASK | 0.58174675 |
| 99 | PRKD2 | 0.57347514 |
| 100 | MYLK | 0.56826565 |
| 101 | TRIB3 | 0.56090061 |
| 102 | NEK6 | 0.55814496 |
| 103 | FYN | 0.55711214 |
| 104 | PDK1 | 0.55444078 |
| 105 | MAP3K1 | 0.55282052 |
| 106 | BLK | 0.53536950 |
| 107 | CAMKK2 | 0.53132478 |
| 108 | STK4 | 0.51697808 |
| 109 | CDK5 | 0.50838464 |
| 110 | STK11 | 0.50461960 |
| 111 | CSK | 0.50380453 |
| 112 | MAPK7 | 0.50138106 |
| 113 | PRKCE | 0.48273703 |
| 114 | FES | 0.48096891 |
| 115 | ROCK1 | 0.47995153 |
| 116 | PRKACB | 0.47612831 |
| 117 | TYRO3 | 0.47203196 |
| 118 | PAK6 | 0.46857222 |
| 119 | TXK | 0.44457544 |
| 120 | MAP2K6 | 0.44258738 |
| 121 | SYK | 0.42433933 |
| 122 | PRKG1 | 0.41959439 |
| 123 | STK10 | 0.41532527 |
| 124 | PRKCZ | 0.40920912 |
| 125 | MARK3 | 0.40754227 |
| 126 | MAPK4 | 0.40217379 |
| 127 | GRK6 | 0.39135357 |
| 128 | MOS | 0.39065716 |
| 129 | MAP2K1 | 0.37782930 |
| 130 | RET | 0.36971486 |
| 131 | CSNK1D | 0.36498457 |
| 132 | SIK2 | 0.36449424 |
| 133 | JAK1 | 0.36167915 |
| 134 | CCNB1 | 0.36075838 |
| 135 | KSR1 | 0.35687271 |
| 136 | BRAF | 0.35047560 |
| 137 | PIK3CG | 0.34738677 |
| 138 | MAPKAPK2 | 0.34520043 |
| 139 | JAK2 | 0.34179194 |
| 140 | DAPK3 | 0.34124924 |
| 141 | BRSK1 | 0.33877993 |
| 142 | RAF1 | 0.32301334 |
| 143 | GSK3A | 0.31757335 |
| 144 | CAMK1 | 0.31398932 |
| 145 | PINK1 | 0.30869635 |
| 146 | KIT | 0.30786105 |
| 147 | HCK | 0.30737077 |
| 148 | PRKACA | 0.30253399 |
| 149 | ARAF | 0.27895699 |
| 150 | CDK14 | 0.27732763 |
| 151 | PRKAA2 | 0.27192571 |
| 152 | NLK | 0.27063745 |
| 153 | LRRK2 | 0.26614724 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.35857158 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.95883173 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.10718424 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.29039522 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 3.05469996 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.03263937 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.89388007 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.86334340 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.83925827 |
| 10 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.64475990 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.53462566 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.43019484 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.38134005 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.36235615 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.26597110 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 2.25628273 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.23330080 |
| 18 | Alzheimers disease_Homo sapiens_hsa05010 | 1.89193802 |
| 19 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.81604383 |
| 20 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.62616123 |
| 21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.60308887 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.53246420 |
| 23 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.48198309 |
| 24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.37887908 |
| 25 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.32611489 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32417067 |
| 27 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.31217137 |
| 28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.30260469 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.30127881 |
| 30 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.26137423 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.23188943 |
| 32 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.22462742 |
| 33 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.18100183 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.17380118 |
| 35 | Glioma_Homo sapiens_hsa05214 | 1.11837120 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.10889243 |
| 37 | Morphine addiction_Homo sapiens_hsa05032 | 1.09324460 |
| 38 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.07840191 |
| 39 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.06711901 |
| 40 | Protein export_Homo sapiens_hsa03060 | 1.06410569 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06271219 |
| 42 | Circadian rhythm_Homo sapiens_hsa04710 | 1.05935187 |
| 43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.04753389 |
| 44 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.03917386 |
| 45 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.02145882 |
| 46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.02073241 |
| 47 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.01383480 |
| 48 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.01319381 |
| 49 | Bile secretion_Homo sapiens_hsa04976 | 1.00296045 |
| 50 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.00134682 |
| 51 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.00092640 |
| 52 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.99025430 |
| 53 | Axon guidance_Homo sapiens_hsa04360 | 0.98746121 |
| 54 | Melanogenesis_Homo sapiens_hsa04916 | 0.95080840 |
| 55 | Gap junction_Homo sapiens_hsa04540 | 0.94265990 |
| 56 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.92169724 |
| 57 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.91988104 |
| 58 | GABAergic synapse_Homo sapiens_hsa04727 | 0.91786385 |
| 59 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.89535164 |
| 60 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89353898 |
| 61 | Circadian entrainment_Homo sapiens_hsa04713 | 0.85867794 |
| 62 | Huntingtons disease_Homo sapiens_hsa05016 | 0.85381174 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85097569 |
| 64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.84642675 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84444278 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.84212527 |
| 67 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.83074148 |
| 68 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78963458 |
| 69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78448269 |
| 70 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.76875493 |
| 71 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.76647217 |
| 72 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.76179770 |
| 73 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76082298 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.71273421 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.69665212 |
| 76 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.69397177 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.69158866 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.67639760 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66895272 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.66697936 |
| 81 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.66340951 |
| 82 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.66240630 |
| 83 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.65958411 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.65808124 |
| 85 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.65658597 |
| 86 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65197443 |
| 87 | Salivary secretion_Homo sapiens_hsa04970 | 0.64325124 |
| 88 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.63718665 |
| 89 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.61499854 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61355091 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60706678 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60255867 |
| 93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.60188586 |
| 94 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.59613620 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.58820838 |
| 96 | Renin secretion_Homo sapiens_hsa04924 | 0.58394550 |
| 97 | * Histidine metabolism_Homo sapiens_hsa00340 | 0.58304515 |
| 98 | Taste transduction_Homo sapiens_hsa04742 | 0.57692994 |
| 99 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57464527 |
| 100 | Platelet activation_Homo sapiens_hsa04611 | 0.55724834 |
| 101 | Tight junction_Homo sapiens_hsa04530 | 0.55411978 |
| 102 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.54905801 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54384564 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.54079688 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52820056 |
| 106 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.52753822 |
| 107 | Cocaine addiction_Homo sapiens_hsa05030 | 0.52258317 |
| 108 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.52034788 |
| 109 | Peroxisome_Homo sapiens_hsa04146 | 0.52008426 |
| 110 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48002295 |
| 111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47802704 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47102528 |
| 113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46259348 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46134957 |
| 115 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45883121 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.45529923 |
| 117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41797511 |
| 118 | Long-term depression_Homo sapiens_hsa04730 | 0.40991548 |
| 119 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.40270694 |
| 120 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.39458102 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38554371 |
| 122 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.36794235 |
| 123 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.36681265 |
| 124 | Viral myocarditis_Homo sapiens_hsa05416 | 0.36290207 |
| 125 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35644719 |
| 126 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34756605 |
| 127 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34118223 |
| 128 | Salmonella infection_Homo sapiens_hsa05132 | 0.33546664 |
| 129 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.33298223 |
| 130 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32999855 |
| 131 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32834044 |
| 132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32499746 |
| 133 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32294415 |
| 134 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.31465038 |
| 135 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.30040046 |
| 136 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.28886738 |
| 137 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.28594950 |
| 138 | Phototransduction_Homo sapiens_hsa04744 | 0.28484526 |
| 139 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28479362 |
| 140 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.27204240 |
| 141 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26665645 |
| 142 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.26589575 |
| 143 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.24358223 |
| 144 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.23782352 |

